Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Pharma’s Clout on Drug Prescriptions
A common sight at virtually every doctor’s office is the presence of one or more members of a pharmaceutical company’s sales team. They are there to talk to the doctor about various products being marketed by their company. We’d like to know how much of an impact you think pharmaceutical companies have in influencing physicians' decisions to prescribe a drug for their patients?